Literature DB >> 17242897

Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery?

Celestino Pio Lombardi1, Marco Raffaelli, Carmela De Crea, Vittoria Rufini, Giorgio Treglia, Rocco Bellantone.   

Abstract

BACKGROUND AND AIMS: The most common causes of hyperaldosteronism (HA) are bilateral idiopathic hyperaldosteronism (IHA), aldosterone-producing adenoma (APA), and unilateral primary adrenal hyperplasia (PAH). We evaluated if non-invasive preoperative imaging studies are able to reliably differentiate these causes of hyperaldosteronism.
METHODS: The medical records of 50 consecutive patients with HA were reviewed. Follow up was obtained by outpatient consultation or phone contact.
RESULTS: Thirty-five patients (70%) underwent successful adrenalectomy for APA, basing on the computed tomography (CT) scan results only. All these patients were biochemically cured. The remaining 15 patients underwent dexamethasone suppression adrenal cortical scintiscan (ACS) because of equivocal or inconclusive CT scan. In 11 of these patients, ACS showed a bilateral uptake, suggesting IHA. They were followed-up. In the remaining four patients, ACS showed a unilateral uptake. These patients underwent adrenalectomy. Final histology showed APA in three patients and PAH in one. They were biochemically cured. Sensitivity of combined non-invasive imaging procedures (CT and ACS) in detecting histologically proven and biochemically cured APA and PAH was 100%.
CONCLUSION: Non-invasive adrenal imaging studies are accurate in distinguishing between IHA and APA/PAH. Invasive diagnostic tests (adrenal venous sampling) should be indicated only when they do not conclusively localize hypersecretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242897     DOI: 10.1007/s00423-006-0137-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  24 in total

1.  Potentially high prevalence of primary aldosteronism in a primary-care population.

Authors:  P O Lim; P Rodgers; K Cardale; A D Watson; T M MacDonald
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

2.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

Review 3.  Primary aldosteronism: A common and curable form of hypertension.

Authors:  W F Young
Journal:  Cardiol Rev       Date:  1999 Jul-Aug       Impact factor: 2.644

Review 4.  Primary aldosteronism: management issues.

Authors:  William F Young
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

5.  Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization.

Authors:  J C Melby; R F Spark; S L Dale; R H Egdahl; P C Kahn
Journal:  N Engl J Med       Date:  1967-11-16       Impact factor: 91.245

6.  Is primary aldosteronism underdiagnosed in clinical practice?

Authors:  B Fiquet-Kempf; P Launay-Mignot; G Bobrie; P F Plouin
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-12       Impact factor: 2.557

7.  Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

Authors:  G P Rossi; A Sacchetto; E Pavan; P Palatini; G R Graniero; C Canali; A C Pessina
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

Review 8.  A review of the medical treatment of primary aldosteronism.

Authors:  P O Lim; W F Young; T M MacDonald
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

9.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

10.  Scintigraphic localization of adrenal lesions in primary aldosteronism.

Authors:  M D Gross; B Shapiro; R J Grekin; J E Freitas; G Glazer; W H Beierwaltes; N W Thompson
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

View more
  4 in total

1.  11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.

Authors:  J Hennings; A Sundin; A Hägg; P Hellman
Journal:  Langenbecks Arch Surg       Date:  2010-07-20       Impact factor: 3.445

2.  Outcome of surgical treatment of primary aldosteronism.

Authors:  Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Franco Mantero; Donato Nitti; Maurizio Iacobone
Journal:  Langenbecks Arch Surg       Date:  2015-01-08       Impact factor: 3.445

3.  Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.

Authors:  J Hennings; S Andreasson; J Botling; A Hägg; A Sundin; P Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

4.  Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism.

Authors:  Insang Hwang; Ari Chong; Jong Beom Kim; Kwang Ho Kim; Dongdeuk Kwon
Journal:  Korean J Urol       Date:  2014-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.